Reducing the play of chance using meta-analysisSystematic reviews of all the relevant, reliable evidence are needed for fair tests of medical treatments. To avoid misleading conclusions about the effects of treatments, people preparing systematic reviews must take steps to avoid biases of various kinds, for example, by taking account of all the relevant evidence and by avoiding biased selection from the available evidence. Even though care may be taken to minimize biases in reviews, misleading conclusions about the effects of treatments may also result from the play of chance. Discussing separate but similar studies one at a time in systematic reviews may also leave a confused impression because of the play of chance. If it is both possible and appropriate, this problem can be reduced by combining the data from all the relevant studies, using a statistical procedure now known as 'meta-analysis'.
An early medical example of meta-analysis was published in the British Medical Journal in 1904 by Karl Pearson (Pearson 1904; O'Rourke 2006), who had been asked by the government to review evidence on the effects of a vaccine against typhoid. Although methods for meta-analysis were developed by statisticians over the subsequent 70 years, it was not until the 1970s that they began to be applied more widely, initially by social scientists (Glass 1976), and then by medical researchers (Stjernswärd J 1974; Stjernsward et al. 1976; Cochran et al. 1977; Chalmers et al. 1977; Chalmers 1979; Editorial 1980).
This diagram shows the results of a systematic review of fair tests of a short, inexpensive course of a steroid drug given to women expected to give birth prematurely. The first of these tests was reported in 1972. The diagram summarises the evidence that would have been revealed had the available tests been reviewed systematically a decade later, in 1981: it indicates strongly that steroids reduce the risk of babies dying from the complications of immaturity. By 1991, seven more trials had been reported, and the picture in the logo had become still stronger. No systematic review of these trials was published until 1989 (Crowley 1989), so most obstetricians, midwives, and pregnant women did not realise that the treatment was so effective. After all, some of the tests had not shown a 'statistically significant' benefit, and maybe only these tests had been noticed. Because no systematic reviews had been done, tens of thousands of premature babies suffered, and many died unnecessarily. This is just one of many examples of the human costs that can result from failure to assess the effects of treatments in systematic, up-to-date reviews of fair tests, using meta-analysis to reduce the likelihood that the play of chance will be misleading. Furthermore, resources were wasted on unnecessary intensive care and research. By the end of the 20th century it had become widely accepted that meta-analysis was an important element of fair tests of treatments, and that it helped to avoid incorrect conclusions that treatments had no effects when they were, in fact, either useful or harmful.
|
||||||